The pathological contributions of a functional ERC-CA connection to the temporal and spatial progression of AD was corroborated recently in mice expressing mutant APP or protein Tau in ERC layers II/III [13], [75]–[77]. This evidence concerns the gene MAPT and Alzheimer disease.